THE CHEMISTRY OF IOMEPROL AND PHYSICOCHEMICAL PROPERTIES OF ITS AQUEOUS-SOLUTIONS AND PHARMACEUTICAL FORMULATIONS

被引：35

作者：

GALLOTTI, A ^{[1
]}

UGGERI, F ^{[1
]}

FAVILLA, A ^{[1
]}

CABRINI, M ^{[1
]}

DEHAEN, C ^{[1
]}

机构：

[1] BRACCO IND CHIM SPA,PRECLIN RES,DIV RES & DEV,I-20134 MILAN,ITALY

来源：

EUROPEAN JOURNAL OF RADIOLOGY | 1994年 / 18卷

关键词：

CONTRAST MEDIA; PHARMACEUTICAL DEVELOPMENT; EFFECTS;

D O I：

10.1016/0720-048X(94)90089-2

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

The synthesis and the chemical characterization of iomeprol, a new triiodinated nonionic radiographic contrast agent, are reported. The physico-chemicaI properties both of aqueous solutions of the pure compound and of its pharmaceutical formulations are presented and these last data are compared with those of other contrast media. The pharmaceutical development of the product is described. Iomeprol is obtained via a synthesis which is particularly friendly to the environment. The compound shows an unusually high solubility which allows the formulation of contrast media with the lowest osmolalities and viscosities as compared with corresponding contrast media of the same category. In view of these favourable characteristics and of the remarkably high stability of its solutions, iomeprol for injection is formulated also at 400 mgI/ml, the highest concentration so far available on the market for non-ionic contrast media.

引用

页码：S1 / S12

页数：12

共 26 条

[1]

Morisetti, Tirone, Luzzani, de Haen, Toxicological safety assessment of iomeprol, a new X-ray contrast agent, Eur J Radiol, 18, pp. S21-S31, (1994)

[2]

La Noce, Bertani, Lorusso, Luzzani, Tirone, de Haen, Preclinical safety assessment of iomeprol for injection as contrast medium for myelography, Eur J Radiol, 18, pp. S43-S50, (1994)

[3]

Lorusso, Luzzani, Bertani, Tirone, de Haen, Pharmacokinetics and tissue distribution of iomeprol in animals, Eur J Radiol, 18, pp. S13-S20, (1994)

[4]

Cipolla, Tirone, Luzzani, de Haen, Pharmacodynamic effects of iomeprol in experimental animals, Eur J Radiol, 18, pp. S32-S42, (1994)

[5]

Rosati, Clinical pharmacology of iomeprol, Eur J Radiol, 18, pp. S51-S60, (1994)

[6]

Musu, Felder, Fumagalli, Piva, Uggeri, Smiles rearrangement: a new synthetic pathway to the synthesis of 5-(hydroxyacyl)-amino-2,4,6-triiodoisophtalamides, Invest Radiol, 25, pp. S100-S101, (1990)

[7]

Felder, Gallotti, Favilla, Molecular rearrangement of 5-(α-hydroxy-alkanoylamino)-2,4,6-triiodoisophthalic acid amides, Invest Radiol, 23, pp. S101-S105, (1988)

[8]

Truce, Kreider, Brand, The Smiles and related rearrangements of aromatic systems, Org React, 18, pp. 99-215, (1970)

[9]

Jacobsen, The preclinical development of iohexol (Omnipaque), Farmakoterapi, 38, pp. 45-57, (1982)

[10]

Baker, Alkoxide—accelerated Smiles rearrangements. Synthesis of N-(2-hydroxyethyl)anilines from N-(2-hydroxyethyl) (aryloxy)acetamides, J Org Chem, 48, pp. 5140-5143, (1983)

← 1 2 3 →